AstraZeneca Unit Settles Soliris Feud With Samsung, Amgen
AstraZeneca subsidiary Alexion has settled its claims in the U.K. that Samsung and Amgen infringed a patent covering blood disease drug Soliris, closing the case several months after the Court of...To view the full article, register now.
Already a subscriber? Click here to view full article